Kyoung-Hee Sohn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kyoung-Hee Sohn has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Hye-Ryun Kang
Drug safety Center, Seoul National University Hospital, Seoul, Korea
13 shared publications - Sang-Heon Cho
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
12 shared publications - Byung-Keun Kim
Division of Respiratory, Allergy, and Critical Care Medicine, Korea University College of Medicine, Korea University Medical Center, Seoul, Republic of Korea
9 shared publications - Woo-Jung Song
Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
9 shared publications - Jae-Woo Jung
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
8 shared publications - Heung-Woo Park
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
7 shared publications
Latest Publications
- 6 May 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (8) , 935-938
Circulating 1‐Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model
Summary Box: Plasma 1‐methylnicotinamide is elevated in dupilumab responders, outperforming conventional type‐2 biomarkers. Combining 1‐methylnicotinamide with FeNO achieves the highest predictive accuracy for dupilumab treatment response.
- 6 May 2026
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 56 (8) , 935-938
Circulating 1‐Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model
Summary Box: Plasma 1‐methylnicotinamide is elevated in dupilumab responders, outperforming conventional type‐2 biomarkers. Combining 1‐methylnicotinamide with FeNO achieves the highest predictive accuracy for dupilumab treatment response.
- Open Access
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (2) , 192-203
Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)
Sohn KH, et al. Allergy Asthma Immunol Res. 2026 Mar;18(2):192-203. https://doi.org/10.4168/aair.2026.18.2.192
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (2) , 192-203
Open AccessImpact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)
Sohn KH, et al. Allergy Asthma Immunol Res. 2026 Mar;18(2):192-203. https://doi.org/10.4168/aair.2026.18.2.192
- Open Access
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (6) , 709-725
Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study
Shim JS, et al. Allergy Asthma Immunol Res. 2025 Nov;17(6):709-725. https://doi.org/10.4168/aair.2025.17.6.709
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (6) , 709-725
Open AccessImpact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study
Shim JS, et al. Allergy Asthma Immunol Res. 2025 Nov;17(6):709-725. https://doi.org/10.4168/aair.2025.17.6.709
- Open Access
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (4) , 447-459
Prevalence and Clinical Characteristics of Severe Asthma With Fungal Sensitization in Korea
Rhyou HI, et al. Allergy Asthma Immunol Res. 2025 Jul;17(4):447-459. https://doi.org/10.4168/aair.2025.17.4.447
- 1 January 2025
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 17 (4) , 447-459
Open AccessPrevalence and Clinical Characteristics of Severe Asthma With Fungal Sensitization in Korea
Rhyou HI, et al. Allergy Asthma Immunol Res. 2025 Jul;17(4):447-459. https://doi.org/10.4168/aair.2025.17.4.447
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (3) , 253-266
Real-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSAR
Park SY, et al. Allergy Asthma Immunol Res. 2024 May;16(3):253-266. https://doi.org/10.4168/aair.2024.16.3.253
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (3) , 253-266
Open AccessReal-World Effectiveness of Biologics in Patients With Severe Asthma: Analysis of the KoSAR
Park SY, et al. Allergy Asthma Immunol Res. 2024 May;16(3):253-266. https://doi.org/10.4168/aair.2024.16.3.253
- Open Access
- 1 January 2023
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 15 (2) , 160-173
Staphylococcal Enterotoxin-Specific IgE Sensitization: A Potential Predictor of Fixed Airflow Obstruction in Elderly Asthma
Won HK, et al. Allergy Asthma Immunol Res. 2023 Mar;15(2):160-173. https://doi.org/10.4168/aair.2023.15.2.160
- 1 January 2023
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 15 (2) , 160-173
Open AccessStaphylococcal Enterotoxin-Specific IgE Sensitization: A Potential Predictor of Fixed Airflow Obstruction in Elderly Asthma
Won HK, et al. Allergy Asthma Immunol Res. 2023 Mar;15(2):160-173. https://doi.org/10.4168/aair.2023.15.2.160
- Open Access
- 15 August 2022
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 15, 1065-1068
Impact of Wearing Face Masks on Patients with Severe Asthma During the COVID-19 Pandemic
Impact of wearing face masks on patients with severe asthma during the COVID-19 pandemic
- 15 August 2022
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 15, 1065-1068
Open AccessImpact of Wearing Face Masks on Patients with Severe Asthma During the COVID-19 Pandemic
Impact of wearing face masks on patients with severe asthma during the COVID-19 pandemic